Clinical Trials Browser

Papillomavirus Infections

NCT05797246 2026-01-26

Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)

DNA Virus Infections, Infections, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Glandular and Epithelial, Papilloma, Pathologic Processes, Recurrence, Respiratory Tract Diseases, Respiratory Tract Infections, Tumor Virus Infections, Virus Diseases, Neoplasms, Squamous Cell, Disease Attributes, Papillomavirus Infections

NCT01693783 2022-11-08

Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancer

Phase 2 Completed

42 enrolled 12 charts

Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT03937791 2021-04-13

Immunotherapy With E7 T Cell Receptor T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions

Phase 2 Terminated

1 enrolled 8 charts

Neoplasms, Squamous Cell, Papillomavirus Infections

NCT04044950 2020-09-22

A Phase II Study of Neoadjuvant E7 TCR T Cell Immunotherapy for Borderline Resectable and Unresectable Stage I HPV-Associated Oropharyngeal Cancer

Phase 2 Withdrawn

Head & Neck

Oropharyngeal Neoplasms, Papillomavirus Infections

NCT01585428 2018-03-07

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers

Phase 2 Completed

29 enrolled 12 charts

GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Papillomavirus Infections

NCT00303823 2015-05-05

Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical Intraepithelial Neoplasia

Phase 2 Completed

98 enrolled 11 charts

Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT00060099 2013-11-06

SGN-00101 in Treating Patients With Cervical Intraepithelial Neoplasia

Phase 2 Unknown

GynecologicOther neoplasm

Uterine Cervical Dysplasia, Precancerous Conditions, Papillomavirus Infections

NCT00054041 2013-01-24

Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia

Phase 2 Completed

84 enrolled

Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections

Clinical Trials

Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients

Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)

Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancer

Immunotherapy With E7 T Cell Receptor T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions

A Phase II Study of Neoadjuvant E7 TCR T Cell Immunotherapy for Borderline Resectable and Unresectable Stage I HPV-Associated Oropharyngeal Cancer

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers

Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical Intraepithelial Neoplasia

SGN-00101 in Treating Patients With Cervical Intraepithelial Neoplasia

Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia